Financial Summary for Q1 FY2026 Ending September (Japanese GAAP) (Consolidated)

Performance Overview

For Q1 of FY2026 ending September, consolidated net sales amounted to JPY 33,842 million, a 0.4% decrease compared to the same period last year. Operating income was JPY 1,887 million (down 2.3% YoY) and ordinary income was JPY 2,216 million (down 13.0% YoY). However, net income attributable to owners of the parent increased by 37.9% YoY to JPY 2,040 million. By segment, Fine Chemicals recorded net sales of JPY 11,067 million (down 1.8% YoY) and operating income of JPY 733 million (up 2.6% YoY). Industrial Products achieved net sales of JPY 9,699 million (up 0.6% YoY) with operating income of JPY 866 million (up 3.3% YoY). Sustainability reported net sales of JPY 2,704 million (up 11.5% YoY) but operating income decreased by 12.8% to JPY 258 million. Life Sciences' net sales were JPY 10,011 million (down 3.3% YoY) and operating income decreased 22.9% to JPY 484 million.

Financial Position and Dividend Status

Total assets increased to JPY 83,661 million from the previous consolidated fiscal year-end, and net assets stood at JPY 52,782 million, with a stable equity ratio of 63.0%. The number of issued shares remained unchanged at 29,007,708 shares. There was no dividend at the end of Q1 for FY2026, with a scheduled year-end dividend of JPY 29 per share, and an expected annual dividend of JPY 58 per share. The earnings guidance remains unchanged from the full-year forecast announced on November 10, 2025, projecting net sales of JPY 130,000 million (2.0% decrease YoY), operating income of JPY 6,200 million (3.6% decrease YoY), and net income attributable to owners of the parent of JPY 4,100 million (11.2% decrease YoY).